Drug intelligence / Profile preview

Zulvac

Development stage
Unknown
Lead developer
Zoetis
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular, Subcutaneous
01

Overview

Zulvac is a line of inactivated veterinary vaccines developed by Zoetis for the active immunization of cattle and sheep against bluetongue virus (BTV). The vaccines contain inactivated virus particles from specific BTV serotypes, such as serotype 1, 4, or 8, and are formulated with adjuvants including aluminium hydroxide and saponin to enhance the immune response. By inducing the production of specific antibodies, Zulvac prevents viraemia—the presence of the virus in the bloodstream—thereby reducing clinical symptoms and limiting the spread of the disease by *Culicoides* midges. The product range includes monovalent formulations (e.g., Zulvac 8) and bivalent combinations (e.g., Zulvac 1+8), with specific versions optimized for cattle (Bovis) and sheep (Ovis).

Brand names
ZulvacZulvac 1Zulvac1Zulvac-1Zulvac 4Zulvac4Zulvac-4Zulvac 8Zulvac8Zulvac-8Zulvac 1+8 BovisZulvac 1+8 OvisZulvac 8 BovisZulvac8 BovisZulvac-8 BovisZulvac 8 OvisZulvac8 OvisZulvac-8 Ovis
Other names
Bluetongue virus vaccine

Beyond the preview

Go deeper on Zulvac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zulvac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call